Introducing Polsky On Demand, a new online portal of Polsky's world-class business and entrepreneurship workshops
Learn more
News //

Patent of the Week: A Predictive Gene Signature for Breast Cancer Therapy

Inventors, including University of Chicago researcher Edwardine Labay, have patented a seven-gene signature that can be used to assess the risk of breast cancer progression and treatment response. The…
News //

Patent of the Week: A Low Dose, Multi-Drug Cocktail for Breast Cancer Treatment

More than 150,000 breast cancer survivors were living with metastatic disease, three-fourths of whom were originally diagnosed with stage I-III, as of January 1, 2019, according to the American…
News //

25 Chicago Startups That Are Fighting Cancer

There are more than 100 types of cancer, and about 40% of men and women will be diagnosed with cancer at some point in their lifetime, according to the National…
News //

Eric Lefkofsky’s Tempus Will Use Data to Help UChicago Battle Breast Cancer

Tempus, the cancer fighting startup from Groupon founder Eric Lefkofsky, wants to give doctors at the University of Chicago data to help better treat breast cancer patients. Read more.

This site uses cookies and other tracking technologies to assist with navigation and your ability to provide feedback, analyze your use of products and services, assist with our promotional and marketing efforts.

Accept